StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by donnell2on Jun 02, 2020 8:58pm

258 Views

Post# 31104366

gotta know when to walk away and when to run

Way too many shares being put out.. ..for someone to buy out this company at a p/e of 15 ( normal business ) with this deal SZLS would need to be worth $750 BILLION .... if they consolidate 100 to1 and with no revenue the pe becomes zero .. do the math... still not good. Best guess ... 20 to 1 consolidation... been through this BS way too many times... always the same story.

Bullboard Posts

Globex Mining: Unveiling Québec’s hidden gold and lithium treasures